13,14-二氢-15-酮-前列腺素F2α 是第一个基本积累的PGF2α代谢产物,由15-酮-PGF2α通过15-羟基前列腺素脱氢酶途径形成。该产物已用于测量PGF2α的体内生成率,并显示出与牛乙酰胆碱酯酶共价结合。 13,14-Dihydro-15-keto-prostaglandin F2α is the first substantially accumulating metabolite of PGF2α , that is formed from 15-keto-PGF2α via the 15-hydroxy prostaglandin dehydrogenase pathway. This product has been used to measure the rate of|in vivo|production of PGF2α, and has been shown to covalently bind to bovine acetylcholine esterase.
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
13,14-Dihydro-15-keto-prostaglandin F2α
Dangerous GoodsCAS number:27376-76-7 molecular formula:C20H34O5
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | 13,14-Dihydro-15-keto-PGF2 | Pulmonary metabolite-pgf2alpha | 15-keto-dihydro-PGF2alpha | SMR000058898 | 13,14-dihydro-15-keto-Prostaglandin F2alpha | 13,14-dihydro-15-keto Prostaglandin F2alpha Lipid Maps(R) MS Standard | 13,14-DIHYDRO-15-KETO-PGF2a | DT | ||
| CAS number | 27376-76-7 | molecular formula | C20H34O5 |
| molecular weight | 354.48 g/mol | Exact mass | - |
| PSA | 94.800 Ų | logp | 2.600 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
pictogram:
GHS07
Signal word:
Warning
Hazard Statement:
H302: 吞食有害 H312: 皮肤接触有害 H332: 吸入有害
Statement of Preventive Measures:
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P302+P352: 如皮肤沾染:用水充分清洗。 P321: 特殊处理(请参阅此标签上的...)。 P501: 将内容物/容器处理到。。。 P264: 处理后要彻底洗手。 P271: 仅在室外或通风良好的地方使用。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS





